| 0 (0%) | 06-12 13:41 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 66.52 | 1-year : | 77.7 |
| Resists | First : | 56.95 | Second : | 66.52 |
| Pivot price | 42.09  |
|||
| Supports | First : | 37.03 | Second : | 24.71 |
| MAs | MA(5) : | 48.18 |
MA(20) : | 41.39 |
| MA(100) : | 36.04 |
MA(250) : | 0 | |
| MACD | MACD : | 4.2 |
Signal : | 3.1 |
| %K %D | K(14,3) : | 83.7 |
D(3) : | 76.6 |
| RSI | RSI(14): 58.1 |
|||
| 52-week | High : | 155.27 | Low : | 14.05 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ IREX ] has closed below upper band by 24.0%. Bollinger Bands are 7.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 54.63 - 54.92 | 54.92 - 55.17 |
| Low: | 48.77 - 49.07 | 49.07 - 49.33 |
| Close: | 49.85 - 50.37 | 50.37 - 50.81 |
Fri, 29 May 2026
Neurotechnology takes top spot in NIST iris recognition evaluation - Biometric Update
Thu, 28 May 2026
Neurotechnology Ranked First Overall in NIST IREX 10 Evaluation - The Killeen Daily Herald
Thu, 28 May 2026
Neurotechnology Ranked First Overall in NIST IREX 10 Evaluation - Technology Org
Tue, 12 May 2026
Leading EB-5 Regional Centers to Participate in the 26th Edition of IREX Residency & Citizenship Conclave, Singapore - Media OutReach Newswire
Thu, 07 May 2026
IREX and Development Gateway Release Higher Education AI Readiness Research - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|